Sudarshan Pharma Industries financials at a glance
Year | Year | 2018 | 2022 | 2023 | 2020 | 2021 | 2024 | 2025 | |
---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
Rp881.45M | Rp0.00M | Rp4.61B | Rp1.48B | Rp1.94B | Rp0.00M | Rp0.00M |
GM % | Gross Margin % |
|
5.59% | 0.00% | 6.58% | 6.83% | 7.23% | 0.00% | 0.00% |
OM | Operating Margin |
|
2.43% | 0.00% | 3.10% | 3.33% | 3.40% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
Rp0.00 | Rp0.00 | |||||
Div. | Dividends |
|
Rp0.00 | Rp0.00 | Rp0.00 | Rp0.00 | Rp0.00 | Rp0.00 | Rp0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
0m | 0m | 0m | 0m | 0m | 24.07m | 0m |
OCF | Operating Cash Flow |
|
Rp-0.08M | Rp0.00M | Rp-287.93M | Rp5.15M | Rp26.75M | Rp0.00M | Rp0.00M |
FCF | Free Cash Flow |
|
Rp-0.65M | Rp0.00M | Rp-431.20M | Rp-35.25M | Rp13.55M | Rp0.00M | Rp0.00M |
FCFS | Free Cash Flow Per Share |
|
Rp-0.15 | Rp0.00 | Rp-17.92 | Rp-3.69 | Rp1.42 | Rp0.00 | Rp0.00 |